{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:06:42Z","timestamp":1789034802048,"version":"build-2803163510"},"reference-count":189,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":176,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gastha.2026.101045","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:37:48Z","timestamp":1783035468000},"page":"101045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Efficacy of Herbal Products for Improving Liver Enzymes and Inflammation in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Network Meta-Analysis"],"prefix":"10.1016","volume":"5","author":[{"given":"Alejandro","family":"Chen Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3660-1304","authenticated-orcid":false,"given":"Yeison","family":"Cruz Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariela Denise","family":"Fermin Madera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revathi Thirumushi","family":"Sairaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana Alexandra","family":"Moreno D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supritha","family":"Chintamaneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Flores Monar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Sanchez Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Advani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushovan","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2237-9536","authenticated-orcid":false,"given":"Ernesto","family":"Calder\u00f3n-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.gastha.2026.101045_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/j.gastha.2026.101045_bib2","doi-asserted-by":"crossref","first-page":"8462","DOI":"10.3390\/ijms25158462","article-title":"NAFLD (MASLD)\/NASH (MASH): does it bother to label at all? A comprehensive narrative review","volume":"25","author":"Sergi","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.gastha.2026.101045_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra2412865","article-title":"Metabolic dysfunction\u2013associated steatotic liver disease","volume":"393","author":"Targher","year":"2025","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.gastha.2026.101045_bib4","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.gastha.2026.101045_bib5","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2337\/dci24-0094","article-title":"Metabolic dysfunction\u2013associated steatotic liver disease (MASLD) in people with diabetes: the need for screening and early intervention. A consensus report of the American Diabetes Association","volume":"48","author":"Cusi","year":"2025","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/HEP.0000000000001112","article-title":"Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD practice guidance","volume":"81","author":"Chen","year":"2025","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gastha.2026.101045_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.gastha.2026.101045_bib9","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.3390\/nu16234150","article-title":"Polyphenol intervention ameliorates non-alcoholic fatty liver disease: an updated comprehensive systematic review","volume":"16","author":"Ranneh","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.gastha.2026.101045_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2022.102843","article-title":"Curcumin as adjuvant treatment in patients with non-alcoholic fatty liver (NAFLD) disease: a systematic review and meta-analysis","volume":"68","author":"Ngu","year":"2022","journal-title":"Complement Ther Med"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12967-024-05011-2","article-title":"The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review","volume":"22","author":"Nie","year":"2024","journal-title":"J Transl Med"},{"issue":"6","key":"10.1016\/j.gastha.2026.101045_bib12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s12664-022-01287-8","article-title":"Systematic review and meta-analysis of the effect of garlic in patients with non-alcoholic fatty liver disease","volume":"41","author":"Rastkar","year":"2022","journal-title":"Indian J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/hep.28813","article-title":"Liver injury from herbal and dietary supplements","volume":"65","author":"Navarro","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2026.101045_bib15","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"33","key":"10.1016\/j.gastha.2026.101045_bib205","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000041868","article-title":"A comprehensive guide to conduct a systematic review and meta-analysis in medical research","volume":"104","author":"Calderon Martinez","year":"2025","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.gastha.2026.101045_bib16","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","article-title":"AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review","volume":"163","author":"Long","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.101045_bib21","series-title":"Revised Cochrane risk-of-bias tool for randomized trials (RoB 2)","author":"Higgins","year":"2019"},{"key":"10.1016\/j.gastha.2026.101045_bib23","series-title":"R: a language and environment for statistical computing","year":"2021"},{"issue":"5","key":"10.1016\/j.gastha.2026.101045_bib24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/jrsm.1406","article-title":"Random-effects meta-analysis of combined outcomes based on reconstructions of individual patient data","volume":"11","author":"Song","year":"2020","journal-title":"Res Synth Methods"},{"issue":"2","key":"10.1016\/j.gastha.2026.101045_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jrsm.11","article-title":"Outlier and influence diagnostics for meta-analysis","volume":"1","author":"Viechtbauer","year":"2010","journal-title":"Res Synth Methods"},{"issue":"7109","key":"10.1016\/j.gastha.2026.101045_bib27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib28","article-title":"CINeMA: software for semiautomated assessment of the confidence in the results of network meta-analysis","volume":"16","author":"Papakonstantinou","year":"2020","journal-title":"Campbell Syst Rev"},{"issue":"4","key":"10.1016\/j.gastha.2026.101045_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"Cinema: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.gastha.2026.101045_bib34","first-page":"143","article-title":"Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients","volume":"34","author":"Askari","year":"2014"},{"issue":"12","key":"10.1016\/j.gastha.2026.101045_bib51","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.3390\/nu17121972","article-title":"Curcumin for inflammation control in individuals with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial","volume":"17","author":"Yaikwawong","year":"2025","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib63","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12944-024-02220-y","article-title":"Silymarin decreases liver stiffness associated with gut microbiota in patients with metabolic dysfunction-associated steatotic liver disease: a randomized, double-blind, placebo-controlled trial","volume":"23","author":"Jin","year":"2024","journal-title":"Lipids Health Dis"},{"issue":"4","key":"10.1016\/j.gastha.2026.101045_bib74","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/17474124.2015.1004312","article-title":"Effects of mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease","volume":"9","author":"Abenavoli","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.gastha.2026.101045_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16652","article-title":"Effects of one-year supplementation with Phyllanthus niruri on fibrosis score and metabolic markers in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial","volume":"9","author":"Abu Hassan","year":"2023","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.gastha.2026.101045_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5812\/hepatmon.102125","article-title":"Effect of beta vulgaris extract on liver enzymes in patients with non-alcoholic fatty liver disease: a randomized clinical trial","volume":"20","author":"Afzali","year":"2020","journal-title":"Hepat Mon"},{"issue":"16","key":"10.1016\/j.gastha.2026.101045_bib77","first-page":"3118","article-title":"Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study","volume":"19","author":"Aller","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.gastha.2026.101045_bib78","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.clnu.2017.05.028","article-title":"Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: a randomized, controlled trial","volume":"37","author":"Amanat","year":"2018","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1016\/j.gastha.2026.101045_bib79","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MEG.0000000000001369","article-title":"Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial","volume":"31","author":"Anushiravani","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gastha.2026.101045_bib80","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/07315724.2017.1392264","article-title":"Comparison of calorie-restricted diet and resveratrol supplementation on anthropometric indices, metabolic parameters, and serum sirtuin-1 levels in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial","volume":"37","author":"Asghari","year":"2018","journal-title":"J Am Coll Nutr"},{"issue":"2","key":"10.1016\/j.gastha.2026.101045_bib81","doi-asserted-by":"crossref","first-page":"307","DOI":"10.15171\/apb.2018.036","article-title":"Effects of pharmacologic dose of resveratrol supplementation on oxidative\/antioxidative status biomarkers in nonalcoholic fatty liver disease patients: a randomized, double-blind, placebo-controlled trial","volume":"8","author":"Asghari","year":"2018","journal-title":"Adv Pharm Bull"},{"issue":"2","key":"10.1016\/j.gastha.2026.101045_bib83","first-page":"50","article-title":"Triple therapy with garlic, silymarin and curcumin in non-alcoholic fatty liver disease: a randomized, placebo-controlled clinical trial","volume":"6","author":"Ataee","year":"2021","journal-title":"Herbal Med J"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib84","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/jrms.jrms_683_21","article-title":"Effect of silymarin on liver size and nonalcoholic fatty liver disease in morbidly obese patients: a randomized double-blind clinical trial","volume":"27","author":"Atarodi","year":"2022","journal-title":"J Res Med Sci"},{"issue":"2","key":"10.1016\/j.gastha.2026.101045_bib85","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/ijp.IJP_17_19","article-title":"Comparison of the efficacy of oral fenugreek seeds hydroalcoholic extract versus placebo in nonalcoholic fatty liver disease; a randomized, triple-blind controlled pilot clinical trial","volume":"52","author":"Babaei","year":"2020","journal-title":"Indian J Pharmacol"},{"issue":"2","key":"10.1016\/j.gastha.2026.101045_bib86","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/ptr.8404","article-title":"Effect of pomegranate peel consumption on liver enzymes, lipid profile, liver steatosis, and hs-CRP in patients with non-alcoholic fatty liver disease: a double-blind, placebo-controlled, randomized clinical trial","volume":"39","author":"Baghdadi","year":"2025","journal-title":"Phytotherapy Res"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib87","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12937-023-00869-2","article-title":"Pomegranate (Punica granatum L.) peel extract ameliorates metabolic syndrome risk factors in patients with non-alcoholic fatty liver disease: a randomized double-blind clinical trial","volume":"22","author":"Barghchi","year":"2023","journal-title":"Nutr J"},{"issue":"2","key":"10.1016\/j.gastha.2026.101045_bib88","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1017\/S0007114519002484","article-title":"Randomised trial of chronic supplementation with a nutraceutical mixture in subjects with non-alcoholic fatty liver disease","volume":"123","author":"Cerletti","year":"2020","journal-title":"Br J Nutr"},{"issue":"12","key":"10.1016\/j.gastha.2026.101045_bib89","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.cgh.2017.04.016","article-title":"A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis","volume":"15","author":"Wah Kheong","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib90","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12967-016-0982-x","article-title":"Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease","volume":"14","author":"Chang","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/j.gastha.2026.101045_bib91","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2015.05.009","article-title":"Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: a randomized controlled trial","volume":"99","author":"Chen","year":"2015","journal-title":"Pharmacol Res"},{"issue":"8","key":"10.1016\/j.gastha.2026.101045_bib92","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/ptr.6406","article-title":"Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled, double-blind clinical trial","volume":"33","author":"Cheraghpour","year":"2019","journal-title":"Phytotherapy Res"},{"issue":"22","key":"10.1016\/j.gastha.2026.101045_bib93","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.3390\/nu14224750","article-title":"The synergic effect of a nutraceutical supplementation associated to a mediterranean hypocaloric diet in a population of overweight\/obese adults with NAFLD","volume":"14","author":"Chiurazzi","year":"2022","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.gastha.2026.101045_bib94","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.3390\/nu11123070","article-title":"Berberis aristata, elaeis guineensis and coffea canephora extracts modulate the insulin receptor expression and improve hepatic steatosis in NAFLD patients: a pilot clinical trial","volume":"11","author":"Cossiga","year":"2019","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.gastha.2026.101045_bib95","first-page":"1","article-title":"Silymarin in combination with vitamin C, vitamin E, coenzyme q10 and selenomethionine to improve liver enzymes and blood lipid profile in NAFLD patients","volume":"56","author":"Curcio","year":"2020","journal-title":"Medicina (Lithuania)"},{"issue":"5","key":"10.1016\/j.gastha.2026.101045_bib96","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11684-021-0880-3","article-title":"Lingguizhugan decoction, a Chinese herbal formula, improves insulin resistance in overweight\/obese subjects with non-alcoholic fatty liver disease: a translational approach","volume":"16","author":"Dai","year":"2022","journal-title":"Front Med"},{"issue":"6","key":"10.1016\/j.gastha.2026.101045_bib97","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/ptr.6972","article-title":"Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: a randomized, double-blind clinical trial","volume":"35","author":"Darvish","year":"2021","journal-title":"Phytotherapy Res"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib98","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12906-019-2465-0","article-title":"Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial","volume":"19","author":"Daneshi-Maskooni","year":"2019","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.gastha.2026.101045_bib99","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ctim.2019.04.014","article-title":"Nigella sativa and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: results from a randomized, double-blind, placebo-controlled, clinical trial","volume":"44","author":"Darand","year":"2019","journal-title":"Complement Ther Med"},{"issue":"9","key":"10.1016\/j.gastha.2026.101045_bib100","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/ptr.6424","article-title":"The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled clinical trial","volume":"33","author":"Darand","year":"2019","journal-title":"Phytotherapy Res"},{"key":"10.1016\/j.gastha.2026.101045_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.hermed.2021.100525","article-title":"Effects of sumac (Rhus coriaria) on lipid profile, leptin and steatosis in patients with non-alcoholic fatty liver disease: a randomized double-blind placebo-controlled trial","volume":"31","author":"Ehsani","year":"2022","journal-title":"J Herb Med"},{"issue":"5-6","key":"10.1016\/j.gastha.2026.101045_bib102","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1024\/0300-9831\/a000292","article-title":"Effects of pomegranate and orange juice on antioxidant status in non-alcoholic fatty liver disease patients: a randomized clinical trial","volume":"85","author":"Ekhlasi","year":"2015","journal-title":"Int J Vitamin Nutr Res"},{"issue":"10","key":"10.1016\/j.gastha.2026.101045_bib103","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.nutres.2014.09.005","article-title":"Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease","volume":"34","author":"Faghihzadeh","year":"2014","journal-title":"Nutr Res"},{"key":"10.1016\/j.gastha.2026.101045_bib104","volume":"6","author":"Famouri","year":"2017"},{"issue":"3-4","key":"10.1016\/j.gastha.2026.101045_bib105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1024\/0300-9831\/a000528","article-title":"No beneficial effects of resveratrol supplementation on atherogenic risk factors in patients with nonalcoholic fatty liver disease","volume":"90","author":"Farzin","year":"2020","journal-title":"Int J Vitamin Nutr Res"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib106","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40795-025-00997-4","article-title":"Effects of resveratrol supplementation on serum concentrations of plasminogen activator inhibitor-1, fibroblast growth factor 21, and adiponectin in patients with nonalcoholic fatty liver disease","volume":"11","author":"Farzin","year":"2025","journal-title":"BMC Nutr"},{"key":"10.1016\/j.gastha.2026.101045_bib107","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8742075","article-title":"Evaluation of the effect derived from silybin with vitamin D and vitamin E administration on clinical, metabolic, endothelial dysfunction, oxidative stress parameters, and serological worsening markers in nonalcoholic fatty liver disease patients","volume":"2019","author":"Federico","year":"2019","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib108","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jff.2014.04.010","article-title":"Effects of green tea catechins on nonalcoholic steatohepatitis (NASH) patients","volume":"9","author":"Fukuzawa","year":"2014","journal-title":"J Funct Foods"},{"issue":"4","key":"10.1016\/j.gastha.2026.101045_bib109","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.43193","article-title":"Effects of turmeric on homocysteine and fetuin-A in patients with nonalcoholic fatty liver disease: a randomized double-blind placebo-controlled study","volume":"19","author":"Ghaffari","year":"2017","journal-title":"Iran Red Crescent Med J"},{"issue":"5-6","key":"10.1016\/j.gastha.2026.101045_bib110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1024\/0300-9831\/a000568","article-title":"Turmeric and chicory seed have beneficial effects on obesity markers and lipid profile in non-alcoholic fatty liver disease (NAFLD)","volume":"89","author":"Ghaffari","year":"2019","journal-title":"Int J Vitamin Nutr Res"},{"issue":"3","key":"10.1016\/j.gastha.2026.101045_bib111","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/19390211.2023.2263788","article-title":"The effects of ginger (Zingiber officinale Roscoe) on non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a randomized double-blinded placebo-controlled clinical trial","volume":"21","author":"Ghoreishi","year":"2024","journal-title":"J Diet Suppl"},{"issue":"10","key":"10.1016\/j.gastha.2026.101045_bib112","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1002\/ptr.7249","article-title":"The effect of pomegranate extract on anthropometric indices, serum lipids, glycemic indicators, and blood pressure in patients with nonalcoholic fatty liver disease: a randomized double-blind clinical trial","volume":"35","author":"Goodarzi","year":"2021","journal-title":"Phytotherapy Res"},{"issue":"8","key":"10.1016\/j.gastha.2026.101045_bib113","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.6099","article-title":"Effects of metformin, pioglitazone, and silymarin treatment on non-alcoholic fatty liver disease: a randomized controlled pilot study","volume":"12","author":"Hajiaghamohammadi","year":"2012","journal-title":"Hepat Mon"},{"issue":"8","key":"10.1016\/j.gastha.2026.101045_bib114","article-title":"Jiangzhi paizhuo decoction combined with silibinin capsules improve the outcomes of metabolic associated fatty liver disease","volume":"19","author":"Hao","year":"2024","journal-title":"Nat Prod Commun"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib115","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1038\/s41467-021-25701-5","article-title":"A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes","volume":"12","author":"Harrison","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.gastha.2026.101045_bib116","volume":"9","author":"Jalal Hashemi","year":"2009"},{"issue":"4","key":"10.1016\/j.gastha.2026.101045_bib117","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3109\/00365521.2015.1107620","article-title":"Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease","volume":"51","author":"Heeb\u00f8ll","year":"2016","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gastha.2026.101045_bib118","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jgr.2020.07.004","article-title":"Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function","volume":"45","author":"Hong","year":"2021","journal-title":"J Ginseng Res"},{"issue":"7","key":"10.1016\/j.gastha.2026.101045_bib119","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.91024","article-title":"Effect of an herbal product on the serum level of liver enzymes in patients with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled trial","volume":"21","author":"Hormati","year":"2019","journal-title":"Iran Red Crescent Med J"},{"key":"10.1016\/j.gastha.2026.101045_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2019.102290","article-title":"Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver disease: a randomized, controlled trial","volume":"49","author":"Hosseinabadi","year":"2020","journal-title":"Complement Ther Med"},{"issue":"3","key":"10.1016\/j.gastha.2026.101045_bib121","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.59183","article-title":"Efficacy of black seed (Nigella sativa) and lemon balm (Melissa officinalis) on non-alcoholic fatty liver disease: a randomized controlled clinical trial","volume":"20","author":"Hosseini","year":"2018","journal-title":"Iran Red Crescent Med J"},{"key":"10.1016\/j.gastha.2026.101045_bib122","article-title":"Evaluation of the effect of phytosomal curcuminoids on oxidative stress and inflammatory markers in NAFLD: a randomized double-blind placebo-controlled trial","volume":"96","author":"Ali","year":"2022","journal-title":"J Funct Foods"},{"issue":"6","key":"10.1016\/j.gastha.2026.101045_bib123","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1108\/NFS-10-2019-0321","article-title":"Quercetin supplementation in non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled clinical trial","volume":"50","author":"Hosseinikia","year":"2020","journal-title":"Nutr Food Sci"},{"issue":"4","key":"10.1016\/j.gastha.2026.101045_bib124","doi-asserted-by":"crossref","first-page":"931","DOI":"10.12669\/pjms.334.12571","article-title":"Therapeutic benefits of green tea extract on various parameters in non-alcoholic fatty liver disease patients","volume":"33","author":"Hussain","year":"2017","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.gastha.2026.101045_bib125","volume":"29","author":"Hussain","year":"2017"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib126","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ptr.6826","article-title":"Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: a double-blind randomized controlled clinical trial","volume":"35","author":"Izadi","year":"2021","journal-title":"Phytotherapy Res"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102693","article-title":"Effectiveness of the pomegranate extract in improving hepatokines and serum biomarkers of non-alcoholic fatty liver disease: a randomized double blind clinical trial","volume":"17","author":"Jafarirad","year":"2023","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"issue":"10","key":"10.1016\/j.gastha.2026.101045_bib128","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1002\/fsn3.4348","article-title":"Impact of silymarin-supplemented cookies on liver enzyme and inflammatory markers in non-alcoholic fatty liver disease patients","volume":"12","author":"Jaffar","year":"2024","journal-title":"Food Sci Nutr"},{"key":"10.1016\/j.gastha.2026.101045_bib129","first-page":"61","article-title":"The effect of Liv.52 DS in metabolic dysfunction-associated fatty liver disease (MAFLD): a pilot, randomized, double-blind, placebo-controlled, clinical study","volume":"17","author":"Jalihal","year":"2025","journal-title":"Hepat Med"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13098-021-00731-7","article-title":"The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial","volume":"13","author":"Jarhahzadeh","year":"2021","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.gastha.2026.101045_bib132","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6693887","article-title":"The efficacy of plantago major seed on liver enzymes in nonalcoholic fatty liver disease: a randomized double-blind clinical trial","volume":"2021","author":"Jazayeri","year":"2021","journal-title":"Evid Based Complement Altern Med"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib133","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12986-019-0331-1","article-title":"Nano-curcumin improves glucose indices, lipids, inflammation, and nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial","volume":"16","author":"Jazayeri-Tehrani","year":"2019","journal-title":"Nutr Metab (Lond)"},{"issue":"32","key":"10.1016\/j.gastha.2026.101045_bib134","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.3748\/wjg.v23.i32.5977","article-title":"New botanical drug, HL tablet, reduces hepatic fat as measured by magnetic resonance spectroscopy in patients with nonalcoholic fatty liver disease: a placebo-controlled, randomized, phase II trial","volume":"23","author":"Jeong","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gastha.2026.101045_bib135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3736\/jcim20080205","article-title":"Effectiveness of danning tablet in patients with non-alcoholic fatty liver of damp-heat syndrome type: a multicenter randomized controlled trial","volume":"6","author":"Ji","year":"2008","journal-title":"J Chin Integr Med"},{"key":"10.1016\/j.gastha.2026.101045_bib136","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/965723","article-title":"The efficacy and safety of traditional Chinese medicine (Jiang Zhi Granule) for nonalcoholic fatty liver: a multicenter, randomized, placebo-controlled study","volume":"2013","author":"Pan","year":"2013","journal-title":"Evid Based Complement Altern Med"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib138","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3746\/pnf.2022.27.1.37","article-title":"Effect of turmeric supplementation on blood pressure and serum levels of sirtuin 1 and adiponectin in patients with nonalcoholic fatty liver disease: a double-blind, randomized, placebo-controlled trial","volume":"27","author":"Kalhori","year":"2022","journal-title":"Prev Nutr Food Sci"},{"issue":"2","key":"10.1016\/j.gastha.2026.101045_bib139","article-title":"The effect of berberis vulgaris extract on transaminase activities in non-alcoholic fatty liver disease","volume":"15","author":"Kashkooli","year":"2015","journal-title":"Hepat Mon"},{"key":"10.1016\/j.gastha.2026.101045_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctcp.2020.101259","article-title":"The effects of sumac (Rhus coriaria L.) powder supplementation in patients with non-alcoholic fatty liver disease: a randomized controlled trial","volume":"41","author":"Kazemi","year":"2020","journal-title":"Complement Ther Clin Pract"},{"issue":"4","key":"10.1016\/j.gastha.2026.101045_bib141","doi-asserted-by":"crossref","first-page":"645","DOI":"10.15171\/apb.2017.077","article-title":"Effect of daily caper fruit pickle consumption on disease regression in patients with non-alcoholic fatty liver disease: a double-blinded randomized clinical trial","volume":"7","author":"Khavasi","year":"2017","journal-title":"Adv Pharm Bull"},{"issue":"6","key":"10.1016\/j.gastha.2026.101045_bib142","article-title":"Daily consumption of the Capparis spinosa reduces some atherogenic indices in patients with non-alcoholic fatty liver disease: a randomized, double-blind, clinical trial","volume":"20","author":"Khavasi","year":"2018","journal-title":"Iran Red Crescent Med J"},{"key":"10.1016\/j.gastha.2026.101045_bib143","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jep.2019.01.009","article-title":"Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: a randomized, double-blind and placebo-controlled clinical trial","volume":"234","author":"Khonche","year":"2019","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"10.1016\/j.gastha.2026.101045_bib144","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/ph16040623","article-title":"A phase 2a, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of ALS-L1023 in non-alcoholic fatty liver disease","volume":"16","author":"Kim","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.gastha.2026.101045_bib145","first-page":"291","article-title":"Does berberine impact anthropometric, hepatic, and metabolic parameters in patients with metabolic dysfunction-associated fatty liver disease? Randomized, double-blind, placebo-controlled trial","volume":"75","author":"Koperska","year":"2024","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.gastha.2026.101045_bib146","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clnesp.2024.06.003","article-title":"Effects of Silybum marianum, Pueraria lobate, combined with Salvia miltiorrhiza tablets on non-alcoholic fatty liver disease in adults: a triple-blind, randomized, placebo-controlled clinical trial","volume":"63","author":"Li","year":"2024","journal-title":"Clin Nutr ESPEN"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib147","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11655-010-0023-1","article-title":"Treatment of non-alcoholic fatty liver disease by qianggan capsule","volume":"16","author":"Li","year":"2010","journal-title":"Chin J Integr Med"},{"issue":"3","key":"10.1016\/j.gastha.2026.101045_bib148","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ajcnut.2024.07.013","article-title":"Quercetin intervention reduced hepatic fat deposition in patients with nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled crossover clinical trial","volume":"120","author":"Li","year":"2024","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.gastha.2026.101045_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155398","article-title":"Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial","volume":"130","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"issue":"9","key":"10.1016\/j.gastha.2026.101045_bib150","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.freeradbiomed.2012.02.008","article-title":"Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial","volume":"52","author":"Loguercio","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.gastha.2026.101045_bib151","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1201186","article-title":"A scientifically validated combination of garcinol, curcuminoids, and piperine for mild to moderate nonalcoholic steatohepatitis patients\u2014results from a randomized, double-blind, placebo-controlled study","volume":"10","author":"Majeed","year":"2023","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib152","first-page":"9","article-title":"Sylimarin versus essential phospholipids in metabolic associated steatotic liver disease (MASLD) \u2013 a prospective comparative randomized trial","volume":"19","author":"Manuc","year":"2024","journal-title":"Maedica"},{"issue":"2","key":"10.1016\/j.gastha.2026.101045_bib153","doi-asserted-by":"crossref","DOI":"10.34172\/ipp.2022.28262","article-title":"The therapeutic effects of chicory seed aqueous extract on cardio-metabolic profile and liver enzymes in nonalcoholic fatty liver disease; a double blind randomized clinical trial","volume":"10","author":"Marzban","year":"2024","journal-title":"Immunopathologia Persa"},{"issue":"3","key":"10.1016\/j.gastha.2026.101045_bib154","first-page":"181","article-title":"Effects of silymarin on reducing liver aminotransferases in patients with nonalcoholic fatty liver diseases","volume":"18","author":"Masoodi","year":"2013","journal-title":"Govaresh"},{"key":"10.1016\/j.gastha.2026.101045_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.hermed.2024.100986","article-title":"Evaluating the therapeutic efficacy of Habb-e-Ghafis in non-alcoholic fatty liver disease, a randomised, single-blind, standard-controlled trial","volume":"50","author":"Mehraj","year":"2025","journal-title":"J Herb Med"},{"key":"10.1016\/j.gastha.2026.101045_bib156","volume":"26","author":"Akbar","year":"2015"},{"key":"10.1016\/j.gastha.2026.101045_bib157","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-030-64872-5_3","article-title":"The effect of curcumin phytosome on the treatment of patients with non-alcoholic fatty liver disease: a double-blind, randomized, placebo-controlled trial","volume":"1308","author":"Mirhafez","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.gastha.2026.101045_bib158","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-3-030-73234-9_2","article-title":"Curcumin and piperine combination for the treatment of patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled trial","volume":"1328","author":"Mirhafez","year":"2021","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.gastha.2026.101045_bib159","doi-asserted-by":"crossref","first-page":"183","DOI":"10.15403\/jgld-179","article-title":"Effect of phytosomal curcumin on circulating levels of adiponectin and leptin in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled clinical trial","volume":"28","author":"Mirhafez","year":"2019","journal-title":"J Gastrointest Liver Dis"},{"issue":"3-4","key":"10.1016\/j.gastha.2026.101045_bib160","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1024\/0300-9831\/a000629","article-title":"Efficacy of phytosomal curcumin among patients with non-alcoholic fatty liver disease","volume":"91","author":"Mirhafez","year":"2021","journal-title":"Int J Vitamin Nutr Res"},{"key":"10.1016\/j.gastha.2026.101045_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2022.100190","article-title":"Effect of 8 weeks milk thistle powder (silymarin extract) supplementation on fatty liver disease in patients candidates for bariatric surgery","volume":"14","author":"Mirhashemi","year":"2022","journal-title":"Metabol Open"},{"issue":"3","key":"10.1016\/j.gastha.2026.101045_bib162","first-page":"338","article-title":"The efficacy of sumac (Rhus coriaria L.) powder supplementation in biochemical and anthropometric measurements in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized controlled trial","volume":"14","author":"Mohit","year":"2024","journal-title":"Avicenna J Phytomed"},{"key":"10.1016\/j.gastha.2026.101045_bib163","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6628911","article-title":"The efficacy of Rosa damascena on liver enzymes in nonalcoholic fatty liver disease: a randomized double-blind clinical trial","volume":"2021","author":"Moravej","year":"2021","journal-title":"Evid Based Complement Altern Med"},{"issue":"3","key":"10.1016\/j.gastha.2026.101045_bib164","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jtcme.2020.02.004","article-title":"The synergistic effect of Citrus bergamia and Cynara cardunculus extracts on vascular inflammation and oxidative stress in non-alcoholic fatty liver disease","volume":"10","author":"Musolino","year":"2020","journal-title":"J Tradit Complement Med"},{"issue":"6","key":"10.1016\/j.gastha.2026.101045_bib166","first-page":"615","article-title":"Effect of nano-micelle curcumin on hepatic enzymes: a new treatment approach for non-alcoholic fatty liver disease (NAFLD)","volume":"13","author":"Namdar","year":"2023","journal-title":"Avicenna J Phytomed"},{"issue":"11","key":"10.1016\/j.gastha.2026.101045_bib167","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14852","article-title":"Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight\/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial","volume":"75","author":"Namkhah","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"15","key":"10.1016\/j.gastha.2026.101045_bib168","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.3390\/nu14153224","article-title":"Curcumin offers no additional benefit to lifestyle intervention on cardiometabolic status in patients with non-alcoholic fatty liver disease","volume":"14","author":"Naseri","year":"2022","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.gastha.2026.101045_bib169","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221683","article-title":"Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: a randomized, double-blind, placebo controlled trial","volume":"14","author":"Navarro","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.gastha.2026.101045_bib170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/07315724.2016.1267597","article-title":"Turmeric supplementation improves serum glucose indices and leptin levels in patients with nonalcoholic fatty liver diseases","volume":"36","author":"Navekar","year":"2017","journal-title":"J Am Coll Nutr"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib171","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41598-024-51726-z","article-title":"The impact of piperine on the metabolic conditions of patients with NAFLD and early cirrhosis: a randomized double-blind controlled trial","volume":"14","author":"Nouri-Vaskeh","year":"2024","journal-title":"Sci Rep"},{"issue":"04","key":"10.1016\/j.gastha.2026.101045_bib173","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-0043-100019","article-title":"Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial","volume":"67","author":"Panahi","year":"2017","journal-title":"Drug Res"},{"issue":"7","key":"10.1016\/j.gastha.2026.101045_bib174","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/ptr.6073","article-title":"Efficacy of artichoke leaf extract in non-alcoholic fatty liver disease: a pilot double-blind randomized controlled trial","volume":"32","author":"Panahi","year":"2018","journal-title":"Phytotherapy Res"},{"issue":"9","key":"10.1016\/j.gastha.2026.101045_bib175","doi-asserted-by":"crossref","first-page":"15989","DOI":"10.1002\/jcb.28877","article-title":"Curcuminoids plus piperine improve nonalcoholic fatty liver disease: a clinical trial","volume":"120","author":"Panahi","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.gastha.2026.101045_bib176","article-title":"The effects of crocus sativus extract on serum lipid profile and liver enzymes in patients with non-alcoholic fatty liver disease: a randomized placebo-controlled study","volume":"17","author":"Parsi","year":"2020","journal-title":"Obes Med"},{"key":"10.1016\/j.gastha.2026.101045_bib177","first-page":"1","article-title":"The effect of green tea extract supplementation on liver enzymes in patients with nonalcoholic fatty liver disease","volume":"2015","author":"Pezeshki","year":"2015","journal-title":"Int J Prev Med"},{"issue":"12","key":"10.1016\/j.gastha.2026.101045_bib178","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1002\/ptr.6791","article-title":"The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: a double-blind randomized clinical trial","volume":"34","author":"Pour","year":"2020","journal-title":"Phytotherapy Res"},{"key":"10.1016\/j.gastha.2026.101045_bib179","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/CEG.S234698","article-title":"Effect of ginger powder supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial","volume":"13","author":"Rafie","year":"2020","journal-title":"Clin Exp Gastroenterol"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib180","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.34897","article-title":"Ginger supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study","volume":"16","author":"Rahimlou","year":"2016","journal-title":"Hepat Mon"},{"key":"10.1016\/j.gastha.2026.101045_bib181","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/ptr.5659","article-title":"Treatment of non-alcoholic fatty liver disease with curcumin: a randomized placebo-controlled trial","volume":"30","author":"Rahmani","year":"2016","journal-title":"Phytotherapy Res"},{"issue":"7","key":"10.1016\/j.gastha.2026.101045_bib182","doi-asserted-by":"crossref","first-page":"361","DOI":"10.31989\/ffhd.v12i7.958","article-title":"A blend of Sphaeranthus indicus flower head and Terminalia chebula fruit extracts reduces fatty liver and improves liver function in non-alcoholic, overweight adults","volume":"12","author":"Pothula Rajendra","year":"2022","journal-title":"Funct Foods Health Dis"},{"key":"10.1016\/j.gastha.2026.101045_bib183","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4030476","article-title":"The effect of artichoke leaf extract on alanine aminotransferase and aspartate aminotransferase in the patients with nonalcoholic steatohepatitis","volume":"2016","author":"Rangboo","year":"2016","journal-title":"Int J Hepatol"},{"issue":"2","key":"10.1016\/j.gastha.2026.101045_bib184","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s40200-019-00439-6","article-title":"The effect of Nigella sativa oil on serum levels of inflammatory markers, liver enzymes, lipid profile, insulin and fasting blood sugar in patients with non-alcoholic fatty liver","volume":"18","author":"Rashidmayvan","year":"2019","journal-title":"J Diabetes Metab Disord"},{"issue":"10","key":"10.1016\/j.gastha.2026.101045_bib185","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1002\/ptr.7543","article-title":"Effects of licorice root supplementation on liver enzymes, hepatic steatosis, metabolic and oxidative stress parameters in women with nonalcoholic fatty liver disease: a randomized double-blind clinical trial","volume":"36","author":"Rostamizadeh","year":"2022","journal-title":"Phytotherapy Res"},{"issue":"3","key":"10.1016\/j.gastha.2026.101045_bib186","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41430-018-0382-9","article-title":"The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease","volume":"73","author":"Saadati","year":"2019","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib187","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12876-019-1055-4","article-title":"Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial","volume":"19","author":"Saadati","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gastha.2026.101045_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2020.102322","article-title":"Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: a randomized controlled trial","volume":"49","author":"Saberi-Karimian","year":"2020","journal-title":"Complement Ther Med"},{"key":"10.1016\/j.gastha.2026.101045_bib189","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1163950","article-title":"The effect of curcumin on anthropometric indices, blood pressure, lipid profiles, fasting blood glucose, liver enzymes, fibrosis, and steatosis in non-alcoholic fatty livers","volume":"10","author":"Safari","year":"2023","journal-title":"Front Nutr"},{"issue":"5","key":"10.1016\/j.gastha.2026.101045_bib190","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3892\/ijmm.2013.1503","article-title":"Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study","volume":"32","author":"Sakata","year":"2013","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.gastha.2026.101045_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2020.102428","article-title":"Effects of garlic powder supplementation on insulin resistance, oxidative stress, and body composition in patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial","volume":"51","author":"Sangouni","year":"2020","journal-title":"Complement Ther Med"},{"issue":"4","key":"10.1016\/j.gastha.2026.101045_bib192","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1017\/S0007114520001403","article-title":"Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial","volume":"124","author":"Sangouni","year":"2020","journal-title":"Br J Nutr"},{"issue":"12","key":"10.1016\/j.gastha.2026.101045_bib193","first-page":"1","article-title":"Evaluating the efficacy of carum copticum seeds on the treatment of patients with nonalcoholic fatty liver disease: a multi-center, randomized, triple-blind, placebo-controlled clinical trial study","volume":"20","author":"Shafiezadeh","year":"2020","journal-title":"Hepat Mon"},{"key":"10.1016\/j.gastha.2026.101045_bib194","volume":"2024","author":"Shahbazi","year":"2024"},{"issue":"4","key":"10.1016\/j.gastha.2026.101045_bib195","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.45609","article-title":"Effects of green coffee bean extract supplementation on patients with non-alcoholic fatty liver disease: a randomized clinical trial","volume":"17","author":"Shahmohammadi","year":"2017","journal-title":"Hepat Mon"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib196","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12906-024-04692-y","volume":"25","author":"Shaker","year":"2025","journal-title":"BMC Complement Med Ther"},{"issue":"6","key":"10.1016\/j.gastha.2026.101045_bib197","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/ptr.7764","article-title":"Efficacy of curcumin plus piperine co-supplementation in moderate-to-high hepatic steatosis: a double-blind, randomized, placebo-controlled clinical trial","volume":"37","author":"Sharifi","year":"2023","journal-title":"Phytotherapy Res"},{"key":"10.1016\/j.gastha.2026.101045_bib198","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.2147\/DMSO.S254555","article-title":"Therapeutic effects of garlic on hepatic steatosis in nonalcoholic fatty liver disease patients: a randomized clinical trial","volume":"13","author":"Soleimani","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"12","key":"10.1016\/j.gastha.2026.101045_bib200","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.14993","article-title":"Green tea in non-alcoholic fatty liver disease: a double blind randomized clinical trial","volume":"17","author":"Tabatabaee","year":"2017","journal-title":"Hepat Mon"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib202","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41430-020-0679-3","article-title":"The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial","volume":"75","author":"Yari","year":"2021","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.gastha.2026.101045_bib203","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ctim.2018.09.010","article-title":"The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: a randomized double-blind placebo-controlled clinical trial","volume":"41","author":"Zamani","year":"2018","journal-title":"Complement Ther Med"},{"issue":"4","key":"10.1016\/j.gastha.2026.101045_bib204","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ctim.2007.08.004","article-title":"The effect of QuYuHuaTanTongLuo Decoction on the non-alcoholic steatohepatitis","volume":"16","author":"Zhang","year":"2008","journal-title":"Complement Ther Med"},{"issue":"2","key":"10.1016\/j.gastha.2026.101045_bib59","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/HEP.0000000000000937","article-title":"Effect of phospholipid curcumin Meriva on liver histology and kidney disease in nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial","volume":"81","author":"Musso","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2026.101045_bib172","author":"Panahi"},{"key":"10.1016\/j.gastha.2026.101045_bib199","author":"Solhi"},{"issue":"5","key":"10.1016\/j.gastha.2026.101045_bib31","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/HEP.0000000000001608","article-title":"Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD practice guidance","volume":"83","author":"Bansal","year":"2026","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.gastha.2026.101045_bib32","doi-asserted-by":"crossref","first-page":"950","DOI":"10.14309\/ajg.0000000000003379","article-title":"ACG clinical guideline: malnutrition and nutritional recommendations in liver disease","volume":"120","author":"Singal","year":"2025","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.gastha.2026.101045_bib33","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1002\/ptr.7200","article-title":"What is the influence of cinnamon supplementation on liver enzymes? A systematic review and meta-analysis of randomized controlled trials","volume":"35","author":"Mousavi","year":"2021","journal-title":"Phytotherapy Res"},{"issue":"22","key":"10.1016\/j.gastha.2026.101045_bib35","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1080\/10408398.2021.1896473","article-title":"The beneficial effects of cinnamon among patients with metabolic diseases: a systematic review and dose-response meta-analysis of randomized-controlled trials","volume":"62","author":"Kutbi","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"8","key":"10.1016\/j.gastha.2026.101045_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms25084201","article-title":"Berberine effects in pre-fibrotic stages of non-alcoholic fatty liver disease\u2014clinical and pre-clinical overview and systematic review of the literature","volume":"25","author":"Ionita-Radu","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.gastha.2026.101045_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2025.19615","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults: a review","volume":"335","author":"Tilg","year":"2026","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.gastha.2026.101045_bib38","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3390\/nu10091153","article-title":"Nutraceutical approach to non-alcoholic fatty liver disease (NAFLD): the available clinical evidence","volume":"10","author":"Cicero","year":"2018","journal-title":"Nutrients"},{"issue":"19","key":"10.1016\/j.gastha.2026.101045_bib39","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.3390\/molecules29194576","article-title":"A descriptive review of the antioxidant effects and mechanisms of action of berberine and silymarin","volume":"29","author":"Garc\u00eda-Mu\u00f1oz","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.gastha.2026.101045_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116927","article-title":"Chinese herbal medicines: the modulator of nonalcoholic fatty liver disease targeting oxidative stress","volume":"318","author":"Gong","year":"2024","journal-title":"J Ethnopharmacol"},{"issue":"11","key":"10.1016\/j.gastha.2026.101045_bib41","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.3390\/molecules28114491","article-title":"A descriptive review of the action mechanisms of berberine, quercetin and silymarin on insulin resistance\/hyperinsulinemia and cardiovascular prevention","volume":"28","author":"Bellavite","year":"2023","journal-title":"Molecules"},{"issue":"08","key":"10.1016\/j.gastha.2026.101045_bib42","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1142\/S0192415X24500915","article-title":"Cinnamon for metabolic diseases and their cardiovascular and hepatic complications: a mechanistic review","volume":"52","author":"Wu","year":"2024","journal-title":"Am J Chin Med (Gard City N Y)"},{"issue":"13","key":"10.1016\/j.gastha.2026.101045_bib43","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.3390\/nu14132773","article-title":"Cinnamon as a complementary therapeutic approach for dysglycemia and dyslipidemia control in type 2 diabetes mellitus and its molecular mechanism of action: a review","volume":"14","author":"Silva","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.gastha.2026.101045_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092358","article-title":"Cinnamon extract improves insulin sensitivity in the brain and lowers liver fat in mouse models of obesity","volume":"9","author":"Sartorius","year":"2014","journal-title":"PLoS One"},{"issue":"32","key":"10.1016\/j.gastha.2026.101045_bib45","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1021\/acs.jafc.9b02932","article-title":"Procyanidin C1, a component of cinnamon extracts, is a potential insulin sensitizer that targets adipocytes","volume":"67","author":"Sun","year":"2019","journal-title":"J Agric Food Chem"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-33023-3","article-title":"An updated meta-analysis of effects of curcumin on metabolic dysfunction-associated fatty liver disease based on available evidence from Iran and Thailand","volume":"13","author":"Lukkunaprasit","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-11135-2","article-title":"Curcumin's dual effect on pyroptosis and autophagy in metabolic- associated fatty liver disease: a potential therapeutic strategy","volume":"15","author":"Eldken","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.gastha.2026.101045_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155241","article-title":"Effects of curcumin on non-alcoholic fatty liver disease: a scientific metrogy study","volume":"123","author":"Li","year":"2024","journal-title":"Phytomedicine"},{"issue":"24","key":"10.1016\/j.gastha.2026.101045_bib50","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.3390\/nu15245053","article-title":"Molecular mechanisms of curcumin in the pathogenesis of metabolic dysfunction associated steatotic liver disease","volume":"15","author":"Guariglia","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.gastha.2026.101045_bib52","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.freeradbiomed.2019.06.019","article-title":"Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway","volume":"141","author":"Zhu","year":"2019","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib53","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ajcnut.2024.05.017","article-title":"Curcumin supplementation alleviates hepatic fat content associated with modulation of gut microbiota-dependent bile acid metabolism in patients with nonalcoholic simple fatty liver disease: a randomized controlled trial","volume":"120","author":"He","year":"2024","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.gastha.2026.101045_bib54","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1089\/acm.2017.0085","article-title":"A quantitative assessment of the reporting quality of herbal medicine research: the road to improvement","volume":"24","author":"Naumann","year":"2018","journal-title":"J Altern Complement Med"},{"issue":"8","key":"10.1016\/j.gastha.2026.101045_bib55","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3390\/ph15080939","article-title":"Methods used for enhancing the bioavailability of oral curcumin in randomized controlled trials: a meta-research study","volume":"15","author":"Mimica","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"10","key":"10.1016\/j.gastha.2026.101045_bib56","first-page":"931","article-title":"Therapeutic potential of artichoke in the treatment of fatty liver: a systematic review and meta-analysis","volume":"25","author":"Kamel","year":"2022","journal-title":"J Med Food"},{"issue":"17","key":"10.1016\/j.gastha.2026.101045_bib57","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.3390\/nu14173459","article-title":"Berberine in non-alcoholic fatty liver disease\u2014a review","volume":"14","author":"Koperska","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.gastha.2026.101045_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056560","article-title":"Centre selection for clinical trials and the generalisability of results: a mixed methods study","volume":"8","author":"Gheorghe","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.gastha.2026.101045_bib61","article-title":"Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"13","author":"Yang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.gastha.2026.101045_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1362391","article-title":"The additive effect of herbal medicines on lifestyle modification in the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"15","author":"Kim","year":"2024","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib64","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jacl.2025.10.063","article-title":"Artichoke leaf extract reduces steatosis and decreases liver size in prebariatric patients: a randomized placebo-controlled pilot trial-the \u201cSteatoChoke-Study\u201d","volume":"20","author":"Holl\u00e4nder","year":"2026","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.gastha.2026.101045_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2025.111811","article-title":"Grading of recommendations assessment, development, and evaluation and confidence in network meta-analysis showed moderate to substantial concordance in the evaluation of certainty of the evidence","volume":"184","author":"Minozzi","year":"2025","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.gastha.2026.101045_bib66","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/hep.32689","article-title":"AASLD practice guidance on drug, herbal, and dietary supplement\u2013induced liver injury","volume":"77","author":"Fontana","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gastha.2026.101045_bib67","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gastha.2026.101045_bib68","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMra1816149","article-title":"Drug-induced liver injury\u2014types and phenotypes","volume":"381","author":"Hoofnagle","year":"2019","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.gastha.2026.101045_bib69","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1056\/NEJMra020398","article-title":"Herbal remedies","volume":"347","year":"2002","journal-title":"New Engl J Med"},{"issue":"5","key":"10.1016\/j.gastha.2026.101045_bib70","doi-asserted-by":"crossref","first-page":"878","DOI":"10.14309\/ajg.0000000000001259","article-title":"ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury","volume":"116","author":"Chalasani","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"107(Pt A):","key":"10.1016\/j.gastha.2026.101045_bib71","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.fct.2016.11.001","article-title":"An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series","author":"Brown","year":"2017","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.gastha.2026.101045_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2025.112056","article-title":"A scoping review of critical appraisal tools and user guides for systematic reviews with network meta-analysis: methodological gaps and directions for tool development","volume":"190","author":"Mondragon","year":"2026","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.gastha.2026.101045_bib73","doi-asserted-by":"crossref","first-page":"e2425822","DOI":"10.1001\/jamanetworkopen.2024.25822","article-title":"Estimated exposure to 6 potentially hepatotoxic botanicals in US adults","volume":"7","author":"Likhitsup","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326001664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326001664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:13:59Z","timestamp":1789031639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572326001664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":189,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2772572326001664"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101045","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Efficacy of Herbal Products for Improving Liver Enzymes and Inflammation in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Network Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101045"}}